Preeclampsia is one of the causes of increased maternal mortality and morbidity, based on the Republic of Indonesia Ministry of Health data in 2016, the maternal mortality rate in East Java Province reached 91.00 per 100,000 live births. The highest cause of maternal death in 2016 was preeclampsia / eclampsia, which was 30.90% or as many as 165 people. Preeclampsia can appear at more than 20 weeks' gestation marked by hypertension and accompanied by proteinuria. This study aims to determine the relationship of age, body mass index, and gravida to pregnant women who have preeclampsia at Muhammadiyah Hospital in Surabaya. This type of research uses a cross sectional study, sample selection using total sampling with a minimum sample of 70 samples. Large samples obtained 210 respondents, as many as 105 experienced preeclampsia and 105 respondents did not experience preeclampsia. Based on the results of bivariate statistical tests found age is a risk factor for the incidence of preeclampsia (p: 0.039 <0.05), body mass index is associated with the incidence of preeclampsia (p: 0.002 <0.05) and gravida has no relationship with the incidence of preeclampsia (p: 0.410 > 0.05). Based on the multivariate test, there was an influence of age 36-45 years on the incidence of preeclampsia with a risk of 4.060 times experiencing preeclampsia compared to the age of 20-35 years, obese affected the incidence of preeclampsia with a risk of 4.696 times experiencing preeclampsia compared to normalweight and gravida influencing the incidence of preeclampsia with a risk of 2,099 times experiencing preeclampsia. The conclusion of this research is that there is a relationship between age, body mass index and gravida in preeclampsia at Muhammadiyah Hospital in Surabaya.
Background: Menopause is a condition in which women experience physiological failure of ovarian function, as a result of the loss of activity of the ovarian follicles. Menopause is the stage when a woman's menstrual bleeding stops. At the age of 50 years, women enter menopause so that there is a decrease or loss of the hormone estrogen which causes women to experience complaints or disorders that often interfere with daily activities and can even reduce their quality of life. Objectives: to determine risk factors, pathophysiology, clinical manifestations, diagnosis and management of climacteric. Methods: collecting and analyzing journals using pubmed search media, google scholar, NCBI, ScienceDirect with keywords Conclusion: The climacteric phase consists of premenopause, perimenopause, menopause and postmenopause phases. The premenopause phase is the period for 4-5 years before the onset of menopause. This phase begins when a woman is 40 years old, characterized by irregular, prolonged menstrual cycles, little or a lot of menstrual blood, and sometimes accompanied by pain. The perimenopause phase is a transitional phase between pre-menopausal and postmenopausal. This phase is characterized by irregular menstrual cycles and levels of Follicle Stimulating Hormone (FSH), luteinizing hormone (LH), and highly variable estrogen (normal, high, or low). The menopausal phase is the condition of women who have no longer menstruating calculated after 12 months from the last menstruation, which is characterized by blood FSH levels >35 mIU/ml and estradiol levels <30 pg/ml.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.